Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Román, Gustavo C.
2006.
Vascular Depression: An Archetypal Neuropsychiatric Disorder.
Biological Psychiatry,
Vol. 60,
Issue. 12,
p.
1306.
Robinson-Smith, Gale
and
Grill, Joshua D.
2007.
Recognizing Involuntary Emotional Expression Disorder.
Journal of Neuroscience Nursing,
Vol. 39,
Issue. 4,
p.
202.
Duda, John E.
2007.
History and Prevalence of Involuntary Emotional Expression Disorder.
CNS Spectrums,
Vol. 12,
Issue. S5,
p.
6.
Rabins, Peter V.
and
Arciniegas, David B.
2007.
Pathophysiology of Involuntary Emotional Expression Disorder.
CNS Spectrums,
Vol. 12,
Issue. S5,
p.
17.
Lyketsos, Constantin G.
Kozauer, Nicholas
and
Rabins, Peter V.
2007.
Psychiatric manifestations of neurologic disease: where are we headed?.
Dialogues in Clinical Neuroscience,
Vol. 9,
Issue. 2,
p.
111.
Martin, Caren McHenry
2007.
<b>It's Nothing to Laugh About: Understanding Disorders of Emotional Expression</b>.
The Consultant Pharmacist,
Vol. 22,
Issue. 9,
p.
732.
Cummings, Jeffrey L.
2007.
Involuntary Emotional Expression Disorder: Definition, Diagnosis, and Measurement Scales.
CNS Spectrums,
Vol. 12,
Issue. S5,
p.
11.
Weintraub, Daniel
and
Stern, Matthew B
2007.
Intervening in the neuropsychiatric features of Parkinson’s disease.
Expert Review of Neurotherapeutics,
Vol. 7,
Issue. 6,
p.
699.
Bernal-Pacheco, Oscar
and
Román, Gustavo C.
2007.
Environmental vascular risk factors: New perspectives for stroke prevention.
Journal of the Neurological Sciences,
Vol. 262,
Issue. 1-2,
p.
60.
Rosen, Howard J.
and
Cummings, Jeffrey
2007.
A real reason for patients with pseudobulbar affect to smile.
Annals of Neurology,
Vol. 61,
Issue. 2,
p.
92.
Whitehouse, Peter J.
and
Waller, Sara
2007.
Involuntary Emotional Expressive Disorder: A Case for a Deeper Neuroethics.
Neurotherapeutics,
Vol. 4,
Issue. 3,
p.
560.
Johnston, S. Claiborne
and
Hauser, Stephen L.
2007.
Marketing and drug costs: Who is laughing and crying?.
Annals of Neurology,
Vol. 61,
Issue. 2,
2007.
The Clinical Neuropsychiatry of Multiple Sclerosis.
p.
82.
Werling, Linda L.
Keller, Ashleigh
Frank, Julie G.
and
Nuwayhid, Samer J.
2007.
A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: Treatment of involuntary emotional expression disorder.
Experimental Neurology,
Vol. 207,
Issue. 2,
p.
248.
Murray, Evan D.
and
Price, Bruce Heimburger
2008.
Massachusetts General Hospital Comprehensive Clinical Psychiatry.
p.
997.
Balakrishnan, Preethi
and
Rosen, Howard
2008.
The causes and treatment of pseudobulbar affect in ischemic stroke.
Current Treatment Options in Cardiovascular Medicine,
Vol. 10,
Issue. 3,
p.
216.
Nieuwenhuis-Mark, Ruth Elaine
van Hoek, Anneke
and
Vingerhoets, Ad
2008.
Understanding Excessive Crying in Neurologic Disorders: Nature, Pathophysiology, Assessment, Consequences, and Treatment.
Cognitive and Behavioral Neurology,
Vol. 21,
Issue. 2,
p.
111.
Rottenberg, Jonathan
Bylsma, Lauren M.
Wolvin, Vanessa
and
Vingerhoets, Ad J.J.M.
2008.
Tears of sorrow, tears of joy: An individual differences approach to crying in Dutch females.
Personality and Individual Differences,
Vol. 45,
Issue. 5,
p.
367.
Haussleiter, Ida S.
Brüne, Martin
and
Juckel, Georg
2009.
Review: Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.
Therapeutic Advances in Neurological Disorders,
Vol. 2,
Issue. 1,
p.
13.
Olanow, C. Warren
Stern, Matthew B.
and
Sethi, Kapil
2009.
The scientific and clinical basis for the treatment of Parkinson disease (2009).
Neurology,
Vol. 72,
Issue. 21_supplement_4,